1.
|
Phase: Phase IV
Type: Treatment
Status: Completed
Age: 15 to 65
Sponsor: Other
Protocol IDs: GMALL03, NCT00199004
|
|
2.
|
Phase: Phase IV
Type: Treatment
Status: Completed
Age: 15 to 65
Sponsor: Other
Protocol IDs: GMALL04, NCT00199017
|
|
3.
|
Phase: Phase III, Phase II
Type: Treatment
Status: Closed
Age: no age specified
Sponsor:
Protocol IDs: MDA-MBDT-7848
|
|
4.
|
Phase: Phase III, Phase II
Type: Treatment
Status: Completed
Age: no age specified
Sponsor:
Protocol IDs: MDA-DT-7913
|
|
5.
|
Phase: Phase III, Phase II
Type: Treatment
Status: Closed
Age: no age specified
Sponsor:
Protocol IDs: MDA-DT-8075, NCI-D81-043-098
|
|
6.
|
Phase: Phase III, Phase II
Type: Treatment
Status: Closed
Age: under 70
Sponsor:
Protocol IDs: UCCRC-3248, NCI-D81-014-080
|
|
7.
|
Phase: Phase III, Phase II
Type: Treatment
Status: Closed
Age: 70 and under
Sponsor:
Protocol IDs: EORTC-08842
|
|
8.
|
Phase: Phase III
Type: Treatment
Status: Closed
Age: 18 to 70
Sponsor:
Protocol IDs: CNR-ALPI, EORTC-08952, EU-94043
|
|
9.
|
Phase: Phase III
Type: Treatment
Status: Closed
Age: no age specified
Sponsor:
Protocol IDs: MDA-MBDT-8008
|
|
10.
|
Phase: Phase III
Type: Treatment
Status: Closed
Age: under 21
Sponsor:
Protocol IDs: GER-NB90, EU-96004, NCT00002802
|
|
11.
|
Phase: Phase III
Type: Treatment
Status: Closed
Age: 18 to 75
Sponsor: Other
Protocol IDs: CDR0000065002, FRE-IALT, EU-96010, NCT00002823
|
|
12.
|
Phase: Phase III
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: Other
Protocol IDs: EORTC-55954, MRC-CE04, COSA, EU-98061, NSGO-CC-9502, NCT00003209
|
|
13.
|
Phase: Phase III
Type: Treatment
Status: Closed
Age: Adult
Sponsor:
Protocol IDs: LLCG-BLT, MRC-BLT, EU-98003, NCT00003240
|
|
14.
|
Phase: Phase III
Type: Treatment
Status: Closed
Age: Under 18
Sponsor: Other
Protocol IDs: CDR0000066840, EORTC-58951, NCT00003728
|
|
15.
|
Phase: Phase III
Type: Treatment
Status: Closed
Age: no age specified
Sponsor: NCI
Protocol IDs: NCI-83-C-106, NCI-NMOB-834, NCI-T83-1019N
|
|
16.
|
Phase: Phase III
Type: Treatment
Status: Completed
Age: under 18
Sponsor: NCI
Protocol IDs: CCG-172
|
|
17.
|
Phase: Phase III
Type: Treatment
Status: Completed
Age: no age specified
Sponsor: NCI
Protocol IDs: EST-1581
|
|
18.
|
Phase: Phase III
Type: Treatment
Status: Closed
Age: 14 and over
Sponsor: NCI
Protocol IDs: EST-2782
|
|
19.
|
Phase: Phase III
Type: Treatment
Status: Closed
Age: no age specified
Sponsor:
Protocol IDs: MDA-DT-8029
|
|
20.
|
Phase: Phase III
Type: Treatment
Status: Closed
Age: no age specified
Sponsor: NCI
Protocol IDs: NCI-81-C-118, NCI-T83-0978N, T83-0978
|
|
21.
|
Phase: Phase III
Type: Treatment
Status: Closed
Age: no age specified
Sponsor:
Protocol IDs: MSKCC-8241
|
|
22.
|
Phase: Phase III
Type: Treatment
Status: Closed
Age: under 70
Sponsor:
Protocol IDs: CAN-NCIC-BR5, NCI-V83-0066, BR5
|
|
23.
|
Phase: Phase III
Type: Treatment
Status: Closed
Age: no age specified
Sponsor:
Protocol IDs: SEG-81LUN373
|
|
24.
|
Phase: Phase III
Type: Treatment
Status: Closed
Age: no age specified
Sponsor: NCI
Protocol IDs: MSKCC-8474, NCI-T84-0409D, T84-0409
|
|
25.
|
Phase: Phase III
Type: Treatment
Status: Closed
Age: 15 and over
Sponsor:
Protocol IDs: SEG-LUN-301
|
Mobile | Español
